Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States.
Mink
Chrisanna M
CM
Harbor-UCLA Medical Center, Torrance, CA, USA.
D000293:Adolescent; D000328:Adult; D002648:Child; D004168:Diphtheria Toxoid / Q000008:administration & dosage*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage* / Q000592:standards; D005260:Female; D006801:Humans; D008004:Licensure; D008297:Male; D008875:Middle Aged; D013745:Tetanus Toxoid / Q000008:administration & dosage*; D014481:United States; D014611:Vaccination / Q000331:legislation & jurisprudence / Q000592:standards; D014917:Whooping Cough / Q000517:prevention & control*
D004168:Diphtheria Toxoid; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D013745:Tetanus Toxoid